No abstract available
Keywords:
conditional survival; immunotherapy; prognosis; renal cell carcinoma; risk stratification.
MeSH terms
-
Carcinoma, Renal Cell* / pathology
-
Female
-
Humans
-
Immunotherapy
-
Kidney Neoplasms* / pathology
-
Male
-
Prognosis
Associated data
-
ClinicalTrials.gov/NCT02231749
-
ClinicalTrials.gov/NCT03937219
-
ClinicalTrials.gov/NCT03793166